To better understand the relevance of our findings on the correlation between CCN1 expression and tumour aggressiveness/grade and concentration in matched patient serum, we next investigated the effects of blocking CCN1 in the established glioma cell lines U251 and U87. This evidence concerns the gene CCN1 and central nervous system cancer.